Antibiotic susceptibility testing rapid test URIFAST® 2

enterobacteriaceaelaboratorybiological

URIFAST® 2 evaluates the susceptibility of urinary Enterobacteriaceae to various antibiotics. Each tray allows the testing of 2 specimens. Antibiotic concentrations compliant with EUCAST* recommendations Cost-effective, routine laboratory test “Presto ABG®” standardization High sensitivity and specificity * European Committee on Antimicrobial Susceptibility Testing“ Benefits Intended use Urinary tract infections are the second most important reason for consulting a family practice doctor after respiratory infections. In hospitals, urinary tract infections are the most frequent source of nosocomial infections and are difficult to treat and prevent. Most urinary tract infections are benign. However, infections may become pathological and result in complicated infections such as cystitis, chronic prostatitis, or even pyelonephritis. Diagnosis of urinary tract infections depends on a clinical and biological analysis. This includes the isolation of the germ responsible as well as the assessment of antibiotic susceptibility. The methods for determining minimum inhibitory concentrations (MIC) by diffusion in agar medium as well as by microdilution in liquid medium are lengthy and have proved unsuitable for routine diagnosis or emergency situations. The URIFAST® 2 kit has been designed to determine the susceptibility of Enterobacteriaceae to the most common antibiotics used in the treatment of bacterial urinary tract infections. Principle The determination of antimicrobial susceptibility is based upon the growth or the absence of growth of Enterobacteriaceae in the presence of 9 dehydrated antibiotic agents: amoxicillin, amoxicillin + clavulanic acid, cefuroxime,